Indication-specific tumor evolution and its impact on neoantigen targeting and biomarkers for individualized cancer immunotherapies

Indication-specific tumor evolution and its impact on neoantigen targeting and biomarkers for individualized cancer immunotherapies

Guardado en:
Detalles Bibliográficos
Autores principales: Andrew Wallace, Ryan Jones, Richard Bourgon, Guang-Yu Yang, Amy A Lo, Daniel Oreper, Nicolas Lounsbury, Charles Havnar, Ximo Pechuan-Jorge, Thomas D Wu, Katrina Krogh, Oliver A Zill
Formato: article
Lenguaje:EN
Publicado: BMJ Publishing Group 2021
Materias:
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Acceso en línea:https://doaj.org/article/ae3220fd2a674ad6a63ade71ac6c61d6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ae3220fd2a674ad6a63ade71ac6c61d6
record_format dspace
spelling oai:doaj.org-article:ae3220fd2a674ad6a63ade71ac6c61d62021-11-22T08:00:08ZIndication-specific tumor evolution and its impact on neoantigen targeting and biomarkers for individualized cancer immunotherapies10.1136/jitc-2021-0030012051-1426https://doaj.org/article/ae3220fd2a674ad6a63ade71ac6c61d62021-10-01T00:00:00Zhttps://jitc.bmj.com/content/9/10/e003001.fullhttps://doaj.org/toc/2051-1426Andrew WallaceRyan JonesRichard BourgonGuang-Yu YangAmy A LoDaniel OreperNicolas LounsburyCharles HavnarXimo Pechuan-JorgeThomas D WuKatrina KroghOliver A ZillBMJ Publishing GrouparticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENJournal for ImmunoTherapy of Cancer, Vol 9, Iss 10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Andrew Wallace
Ryan Jones
Richard Bourgon
Guang-Yu Yang
Amy A Lo
Daniel Oreper
Nicolas Lounsbury
Charles Havnar
Ximo Pechuan-Jorge
Thomas D Wu
Katrina Krogh
Oliver A Zill
Indication-specific tumor evolution and its impact on neoantigen targeting and biomarkers for individualized cancer immunotherapies
format article
author Andrew Wallace
Ryan Jones
Richard Bourgon
Guang-Yu Yang
Amy A Lo
Daniel Oreper
Nicolas Lounsbury
Charles Havnar
Ximo Pechuan-Jorge
Thomas D Wu
Katrina Krogh
Oliver A Zill
author_facet Andrew Wallace
Ryan Jones
Richard Bourgon
Guang-Yu Yang
Amy A Lo
Daniel Oreper
Nicolas Lounsbury
Charles Havnar
Ximo Pechuan-Jorge
Thomas D Wu
Katrina Krogh
Oliver A Zill
author_sort Andrew Wallace
title Indication-specific tumor evolution and its impact on neoantigen targeting and biomarkers for individualized cancer immunotherapies
title_short Indication-specific tumor evolution and its impact on neoantigen targeting and biomarkers for individualized cancer immunotherapies
title_full Indication-specific tumor evolution and its impact on neoantigen targeting and biomarkers for individualized cancer immunotherapies
title_fullStr Indication-specific tumor evolution and its impact on neoantigen targeting and biomarkers for individualized cancer immunotherapies
title_full_unstemmed Indication-specific tumor evolution and its impact on neoantigen targeting and biomarkers for individualized cancer immunotherapies
title_sort indication-specific tumor evolution and its impact on neoantigen targeting and biomarkers for individualized cancer immunotherapies
publisher BMJ Publishing Group
publishDate 2021
url https://doaj.org/article/ae3220fd2a674ad6a63ade71ac6c61d6
work_keys_str_mv AT andrewwallace indicationspecifictumorevolutionanditsimpactonneoantigentargetingandbiomarkersforindividualizedcancerimmunotherapies
AT ryanjones indicationspecifictumorevolutionanditsimpactonneoantigentargetingandbiomarkersforindividualizedcancerimmunotherapies
AT richardbourgon indicationspecifictumorevolutionanditsimpactonneoantigentargetingandbiomarkersforindividualizedcancerimmunotherapies
AT guangyuyang indicationspecifictumorevolutionanditsimpactonneoantigentargetingandbiomarkersforindividualizedcancerimmunotherapies
AT amyalo indicationspecifictumorevolutionanditsimpactonneoantigentargetingandbiomarkersforindividualizedcancerimmunotherapies
AT danieloreper indicationspecifictumorevolutionanditsimpactonneoantigentargetingandbiomarkersforindividualizedcancerimmunotherapies
AT nicolaslounsbury indicationspecifictumorevolutionanditsimpactonneoantigentargetingandbiomarkersforindividualizedcancerimmunotherapies
AT charleshavnar indicationspecifictumorevolutionanditsimpactonneoantigentargetingandbiomarkersforindividualizedcancerimmunotherapies
AT ximopechuanjorge indicationspecifictumorevolutionanditsimpactonneoantigentargetingandbiomarkersforindividualizedcancerimmunotherapies
AT thomasdwu indicationspecifictumorevolutionanditsimpactonneoantigentargetingandbiomarkersforindividualizedcancerimmunotherapies
AT katrinakrogh indicationspecifictumorevolutionanditsimpactonneoantigentargetingandbiomarkersforindividualizedcancerimmunotherapies
AT oliverazill indicationspecifictumorevolutionanditsimpactonneoantigentargetingandbiomarkersforindividualizedcancerimmunotherapies
_version_ 1718417814402891776

Ejemplares similares